Cargando…

Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India

A Phase I HIV-1 vaccine trial sponsored by the International AIDS Vaccine Initiative (IAVI) was conducted in India in 2009 to test a subtype C prophylactic vaccine in a prime-boost regimen comprising of a DNA prime (ADVAX) and MVA (TBC-M4) boost. The trial demonstrated that the regimen was safe and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munusamy Ponnan, Sivasankaran, Swaminathan, Soumya, Tiruvengadam, Kannan, K. K., Vidyavijayan, Cheedarla, Narayana, Nesakumar, Manohar, Kathirvel, Sujitha, Goyal, Rajat, Singla, Nikhil, Mukherjee, Joyeeta, Bergin, Philip, T. Kopycinski, Jakub, Gilmour, Jill, Prasad Tripathy, Srikanth, Luke, Hanna Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114930/ https://www.ncbi.nlm.nih.gov/pubmed/30157242 http://dx.doi.org/10.1371/journal.pone.0203037

Ejemplares similares

Evaluation of antiviral T cell responses and T(SCM) cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2020)

Induction and maintenance of bi-functional (IFN-γ (+) IL-2(+) and IL-2(+) TNF-α(+)) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2019)

Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4(+) T Cells in the Pathogenesis of HIV-2 Infection and Disease Progression
por: Ponnan, Sivasankaran Munusamy, et al.
Publicado: (2021)

Elevated Numbers of HIV-Specific Poly-Functional CD8(+) T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2021)

Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2021)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2023)

Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India
por: Vidyavijayan, K. K., et al.
Publicado: (2018)

Comparative codon usage analysis of HIV-1 and HIV-2 genomes
por: Vidyavijayan, KK, et al.
Publicado: (2014)

Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review
por: Daniel, Evangeline Ann, et al.
Publicado: (2021)

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
por: Cheedarla, Narayanaiah, et al.
Publicado: (2018)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
por: Moss, Emaya M., et al.
Publicado: (2023)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

Internalization and Axonal Transport of the HIV Glycoprotein gp120
por: Berth, Sarah, et al.
Publicado: (2015)

At S120
Publicado: (1974)

Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 ± IL-15
por: McKee, Hayley J, et al.
Publicado: (2004)

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis
por: Gopalan, Narendran, et al.
Publicado: (2016)

NMR spectroscopy of HIV-1 gp120 outer domain
por: Sastry, M, et al.
Publicado: (2012)

Behavioral Evidence for a Tau and HIV-gp120 Interaction
por: Vijayan, Murali, et al.
Publicado: (2022)

Structural Basis for Species Selectivity in the HIV-1 gp120-CD4 Interaction: Restoring Affinity to gp120 in Murine CD4 Mimetic Peptides
por: Kassler, Kristin, et al.
Publicado: (2011)

Allosteric Modulation of the HIV-1 gp120-gp41 Association Site by Adjacent gp120 Variable Region 1 (V1) N-Glycans Linked to Neutralization Sensitivity
por: Drummer, Heidi E., et al.
Publicado: (2013)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
por: Visciano, Maria Luisa, et al.
Publicado: (2008)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
por: Rusert, Peter, et al.
Publicado: (2011)

Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity
por: Mathys, Leen, et al.
Publicado: (2014)

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
por: Ambikan, Anoop T., et al.
Publicado: (2022)

Experiment S120
por: Damerell, C
Publicado: (1973)

HLA-C increases HIV-1 infectivity and is associated with gp120
por: Matucci, Andrea, et al.
Publicado: (2008)

The C5 region of HIV-1 gp120 binds specific
por: Dalgleish, A, et al.
Publicado: (2006)

Nitric oxide protects against HIV gp120 endothelial injury
por: Fiorucci, S, et al.
Publicado: (2010)

Structural Plasticity and Conformational Transitions of HIV Envelope Glycoprotein gp120
por: Korkut, Anil, et al.
Publicado: (2012)

Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate
por: Stansell, Elizabeth, et al.
Publicado: (2015)

Helix-A peptide prevents gp120-mediated neuronal loss
por: Avdoshina, Valeria, et al.
Publicado: (2019)

Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120
por: Lee, Young-Jung, et al.
Publicado: (2021)

Recent Advances in the Molecular and Cellular Mechanisms of gp120-Mediated Neurotoxicity
por: Avdoshina, Valeria, et al.
Publicado: (2022)

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists
por: Curreli, Francesca, et al.
Publicado: (2022)

Correction: Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity
Publicado: (2014)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α(4)β(7)
por: Lertjuthaporn, Sakaorat, et al.
Publicado: (2018)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface
por: Torrents de la Peña, Alba, et al.
Publicado: (2021)

Functionalized Graphene Quantum Dot Interfaced Electrochemical Detection of Cardiac Troponin I: An Antibody Free Approach
por: Lakshmanakumar, Muthaiyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p50n68u52gulrhhncvj0a9ibug